IBN expands citrus portfolio with Sytrinol acquisition

Related Articles

FormattedPicture

FOOD RESEARCH

Farlong Pharmaceutical’s ginseng supplement may have a positive influence on reducing cardiovascular disease (CVD) risk by improving blood pressure and HDL-C. This... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Individuals can control their Type 2 diabetes (T2D) through diet, and pharmacists are well-positioned to supervise the transition. One-third of participants with T2D... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

US-based biotech company Conagen is scaling up the natural antioxidant ingredient hydroxytyrosol, thereby expanding its commercial partner Blue California’s health... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Technologies enabling rapid and accessible personalized nutrition are stepping in to ease Europe’s health burden, where half of the population is... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The UK’s National Health Service (NHS) is rolling out soups and shake weight-loss plans that put Type 2 diabetes in remission. The year-long plans provide eligible... Read More

trans